Literature DB >> 25281874

Synthesis of Tat tagged and folate modified N-succinyl-chitosan self-assembly nanoparticles as a novel gene vector.

Cheng-yun Yan1, Ji-wei Gu2, Da-ping Hou2, Hong-ying Jing2, Jing Wang2, Yu-zhi Guo2, Hidemasa Katsumi3, Toshiyasu Sakane3, Akira Yamamoto3.   

Abstract

The purpose of this research was to prepare a novel type of Tat tagged and folate modified N-succinyl-chitosan (Tat-Suc-FA) self-assembly nanoparticles, to provide a new vector for tumor gene therapy. In this study, Tat-Suc-FA polymers was synthesized and characterized using (1)H NMR and FT-IR. The copolymer had a mean diameter of 65 ± 22.6 nm, a zeta potential of 40 ± 0.2 mV. The cytotoxicity assay showed that Tat-Suc-FA polymers were less toxic than chitosan in the tested concentration range (from 2 to 500 μg/ml). Tat-Suc-FA/DNA complexes at various weight ratios were formulated and characterized. Particle sizes of Tat-Suc-FA/DNA complexes were between 54 and 106 nm as determined by dynamic light scattering. Accordingly, Transmission electron microscope photo of Tat-Suc-FA/DNA complexes exhibited a spherical and compact morphology. Zeta potentials of these complexes changed as the weight ratio varied (from 3 to 44 mV). Agarose gel electrophoresis assay showed that Tat-Suc-FA could efficiently condense the DNA, when the weight ratio was above 1.5/1. Together, these results suggest that the low toxic Tat-Suc-FA cationic polymers could be considered for use as a novel type of gene delivery vectors.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Folic acid; Gene delivery; N-Succinyl-chitosan; Self-assembly nanoparticles; Tat peptide

Mesh:

Substances:

Year:  2014        PMID: 25281874     DOI: 10.1016/j.ijbiomac.2014.09.031

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

Review 1.  Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.

Authors:  Iyyakkannu Sivanesan; Shadma Tasneem; Nazim Hasan; Juhyun Shin; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Polymers (Basel)       Date:  2022-05-24       Impact factor: 4.967

2.  Transactivator of transcription (TAT) peptide- chitosan functionalized multiwalled carbon nanotubes as a potential drug delivery vehicle for cancer therapy.

Authors:  Xia Dong; Lanxia Liu; Dunwan Zhu; Hailing Zhang; Xigang Leng
Journal:  Int J Nanomedicine       Date:  2015-06-03

Review 3.  Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid.

Authors:  Buddhadev Layek; Lindsey Lipp; Jagdish Singh
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

Review 4.  Advances in intracellular delivery through supramolecular self-assembly of oligonucleotides and peptides.

Authors:  Jeonghwan Kim; Ashwanikumar Narayana; Siddharth Patel; Gaurav Sahay
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

5.  Development of Covalent Chitosan-Polyethylenimine Derivatives as Gene Delivery Vehicle: Synthesis, Characterization, and Evaluation.

Authors:  Laura Nicolle; Jens Casper; Melanie Willimann; Céline M A Journot; Pascal Detampel; Tomaž Einfalt; Hiu Man Grisch-Chan; Beat Thöny; Sandrine Gerber-Lemaire; Jörg Huwyler
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

6.  Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy.

Authors:  Dandan Jiang; Mingfang Wang; Tianqi Wang; Bo Zhang; Chunxi Liu; Na Zhang
Journal:  Int J Nanomedicine       Date:  2017-12-06

7.  Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.

Authors:  Rong-Hui Deng; Bo Qiu; Pang-Hu Zhou
Journal:  J Mater Sci Mater Med       Date:  2018-10-01       Impact factor: 3.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.